6-(3H-isoindol-5-yl)-N-[6-(4-propan-2-ylpiperazin-1-yl)-3-pyridinyl]imidazo[1,2-a]pyrazin-8-amine
C26H28N8 — CID 148617941
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(3H-isoindol-5-yl)-N-[6-(4-propan-2-ylpiperazin-1-yl)-3-pyridinyl]imidazo[1,2-a]pyrazin-8-amine
6-(3H-isoindol-5-yl)-N-[6-(4-propan-2-ylpiperazin-1-yl)-3-pyridinyl]imidazo[1,2-a]pyrazin-8-amine (PubChem CID 148617941) has the molecular formula C26H28N8 and a molecular weight of 452.57 g/mol. Its IUPAC name is 6-(3H-isoindol-5-yl)-N-[6-(4-propan-2-ylpiperazin-1-yl)-3-pyridinyl]imidazo[1,2-a]pyrazin-8-amine.
Molecular Properties
| Compound Name | 6-(3H-isoindol-5-yl)-N-[6-(4-propan-2-ylpiperazin-1-yl)-3-pyridinyl]imidazo[1,2-a]pyrazin-8-amine |
|---|---|
| PubChem CID | 148617941 |
| Molecular Formula | C26H28N8 |
| Molecular Weight | 452.57 g/mol |
| Exact Mass | 452.24 |
| IUPAC Name | 6-(3H-isoindol-5-yl)-N-[6-(4-propan-2-ylpiperazin-1-yl)-3-pyridinyl]imidazo[1,2-a]pyrazin-8-amine |
| SMILES | CC(C)N1CCN(c2ccc(Nc3nc(-c4ccc5c(c4)CN=C5)cn4ccnc34)cn2)CC1 |
| InChI | InChI=1S/C26H28N8/c1-18(2)32-9-11-33(12-10-32)24-6-5-22(16-29-24)30-25-26-28-7-8-34(26)17-23(31-25)19-3-4-20-14-27-15-21(20)13-19/h3-8,13-14,16-18H,9-12,15H2,1-2H3,(H,30,31) |
| InChIKey | NFRHGQMVKYJSPY-UHFFFAOYSA-N |
| XLogP | 4.00 |
| TPSA | 73.95 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.57 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 148617941 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.